Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis

Citation
Dl. Mattey et al., Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis, J RHEUMATOL, 27(11), 2000, pp. 2611-2616
Citations number
30
Categorie Soggetti
Rheumatology,"da verificare
Journal title
JOURNAL OF RHEUMATOLOGY
ISSN journal
0315162X → ACNP
Volume
27
Issue
11
Year of publication
2000
Pages
2611 - 2616
Database
ISI
SICI code
0315-162X(200011)27:11<2611:ABHASS>2.0.ZU;2-8
Abstract
Objective. To examine the relationship between HLA-DRB1 alleles acid the cl inical expression of the secondary form of Sjogren's syndrome (SS) in patie nts with rheumatoid arthritis (RA). Methods. Typings of HLA-DRB1 alleles was carried out by molecular based tec hniques on DNA obtained from a population of patients with RA from Lugo in northwestern Spain. Patients were diagnosed according to the 1987 American College of Rheumatology criteria for RA, and comprised 137 seropositive and 42 seronegative individuals. Secondary SS was defined by xerostomia and ke ratoconjunctivitis sicca, supported by ophthalmologic examination. Patients were compared with 145 ethnically matched controls. Results. Twenty-two (12.3%) of the patients with RA also had secondary SS. The majority of these (19/22) were rheumatoid factor positive. Eleven (57.9 %) of the seropositive patients with secondary SS carried an HLA-DRB1*15 al lele compared with 28 (23.7%) seropositive patients without secondary SS (O R 4.4, 95% CI 1.5-13.6, p(c) = 0.014). In contrast, the frequency of DRB1*0 4 was reduced in seropositive patients with secondary SS compared to those without secondary SS, although this did not achieve significance after corr ection for multiple testing (OR 0.28, 95% CI 0.09-0.88, p(c) = 0.08). Of no te, in individuals lacking the RA shared epitope (SE), DRB1*15 was found to be associated (OR 2.3, 95% CI 1.0-5.1, p(c) = 0.03) with RA in the absence of secondary SS, No differences were found between DRB1*15 positive and ne gative patients in terms of erosive disease, nodules, or rheumatoid factor positivity. Conclusion. Secondary SS is associated with an increased frequency of HLA-D RB1*15 in seropositive patients with RA from northwestern Spain. HLA-DRB1*1 5 is also associated with RA in SE negative individuals without secondary S S, although the possibility that such patients will later develop SS cannot be ruled out. Further studies are needed to confirm whether the HLA-DRB1*1 5 association with secondary SS in RA is common to Spanish and other ethnic populations.